James Sabry, Roche global head of pharma partnering
Roche, Genentech plunk down $60M upfront to partner with Chinese pharma on PROTAC-based prostate cancer drug
Roche and Genentech are always on the hunt for deals, and on Thursday they found their newest partner.
The pair will team up with the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
